These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 7725596)

  • 41. An in vivo/in vitro experimental model system for the study of human osteosarcoma: canine osteosarcoma cells (COS31) which retain osteoblastic and metastatic properties in nude mice.
    Shoieb AM; Hahn KA; Barnhill MA
    In Vivo; 1998; 12(5):463-72. PubMed ID: 9827352
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Increased renal calcium reabsorption in an animal model of hypercalcemia of human malignancy.
    Shipley PJ; Shevrin DH; Kukreja SC
    J Bone Miner Res; 1988 Oct; 3(5):555-60. PubMed ID: 3195367
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Curcumin analogue UBS109 prevents bone loss in breast cancer bone metastasis mouse model: involvement in osteoblastogenesis and osteoclastogenesis.
    Yamaguchi M; Zhu S; Zhang S; Wu D; Moore TM; Snyder JP; Shoji M
    Cell Tissue Res; 2014 Jul; 357(1):245-52. PubMed ID: 24723227
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Study in 25 patients shows gallium nitrate superior therapy for hypercalcemia in cancer patients.
    Oncology (Williston Park); 1990 Oct; 4(10):57-8. PubMed ID: 2149825
    [No Abstract]   [Full Text] [Related]  

  • 45. Effects of gallium on bone in the rat.
    Wakley GK; Garand J; Brown D; Szukalski BW; Bell NH; Turner RT
    J Bone Miner Res; 1992 Jan; 7(1):11-9. PubMed ID: 1549954
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Gallium nitrate for treatment of refractory hypercalcemia from parathyroid carcinoma.
    Warrell RP; Issacs M; Alcock NW; Bockman RS
    Ann Intern Med; 1987 Nov; 107(5):683-6. PubMed ID: 2821862
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antineoplastic effects of gallium nitrate on human medulloblastoma in vivo.
    Whelan HT; Schmidt MH; Anderson GS; Chan BK; Hunter K; Kubacki D; Segura AD; Chitambar CR
    Pediatr Neurol; 1992; 8(5):323-7. PubMed ID: 1418174
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Separation of parathyroid hormone-like activity from transforming growth factor-alpha and -beta in the canine adenocarcinoma (CAC-8) model of humoral hypercalcemia of malignancy.
    Merryman JI; Rosol TJ; Brooks CL; Capen CC
    Endocrinology; 1989 May; 124(5):2456-63. PubMed ID: 2539981
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ascites sarcoma 180, an animal model of humoral hypercalcemia of malignancy, produces a factor(s) exhibiting potent bone-resorbing activity without any parathyroid hormone-like activity.
    Suzuki K; Yamada S
    Bone Miner; 1991 Jul; 14(1):1-13. PubMed ID: 1651137
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The inhibition of RANKL causes greater suppression of bone resorption and hypercalcemia compared with bisphosphonates in two models of humoral hypercalcemia of malignancy.
    Morony S; Warmington K; Adamu S; Asuncion F; Geng Z; Grisanti M; Tan HL; Capparelli C; Starnes C; Weimann B; Dunstan CR; Kostenuik PJ
    Endocrinology; 2005 Aug; 146(8):3235-43. PubMed ID: 15845617
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The combined effect of tumor-produced parathyroid hormone-related protein and transforming growth factor-alpha enhance hypercalcemia in vivo and bone resorption in vitro.
    Guise TA; Yoneda T; Yates AJ; Mundy GR
    J Clin Endocrinol Metab; 1993 Jul; 77(1):40-5. PubMed ID: 8325957
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Leydig cell tumor induced hypercalcemia in the Fischer rat: morphometric and histochemical evidence for a humoral factor that activates osteoclasts.
    Troyer H; Sowers JR; Babich E
    Am J Pathol; 1982 Sep; 108(3):284-90. PubMed ID: 7114164
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hypercalcemia in dogs with adenocarcinoma derived from apocrine glands of the anal sac. Biochemical and histomorphometric investigations.
    Meuten DJ; Segre GV; Capen CC; Kociba GJ; Voelkel EF; Levine L; Tashjian AH; Chew DJ; Nagode LA
    Lab Invest; 1983 Apr; 48(4):428-35. PubMed ID: 6300551
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Gallium nitrate for acute treatment of cancer-related hypercalcemia: clinicopharmacological and dose response analysis.
    Warrell RP; Skelos A; Alcock NW; Bockman RS
    Cancer Res; 1986 Aug; 46(8):4208-12. PubMed ID: 3731088
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hypercalcemia associated with an adenocarcinoma derived from the apocrine glands of the anal sac.
    Meuten DJ; Cooper BJ; Capen CC; Chew DJ; Kociba GJ
    Vet Pathol; 1981 Jul; 18(4):454-71. PubMed ID: 7257088
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of combination treatment with a vitamin D analog (OCT) and a bisphosphonate (AHPrBP) in a nude mouse model of cancer-associated hypercalcemia.
    Endo K; Katsumata K; Iguchi H; Kubodera N; Teramoto T; Ikeda K; Fujita T; Ogata E
    J Bone Miner Res; 1998 Sep; 13(9):1378-83. PubMed ID: 9738509
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Extracts of porcine pancreas prevent progression of hypercalcemia and cachexia and prolong survival in nude mice bearing a human squamous carcinoma.
    Yoneda T; Takaoka Y; Boyce BF; Scott L; Mundy GR
    Cancer Res; 1994 May; 54(9):2509-13. PubMed ID: 8162601
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Interferon-gamma targets cancer cells and osteoclasts to prevent tumor-associated bone loss and bone metastases.
    Xu Z; Hurchla MA; Deng H; Uluçkan O; Bu F; Berdy A; Eagleton MC; Heller EA; Floyd DH; Dirksen WP; Shu S; Tanaka Y; Fernandez SA; Rosol TJ; Weilbaecher KN
    J Biol Chem; 2009 Feb; 284(7):4658-66. PubMed ID: 19059914
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Interleukin-6 enhances hypercalcemia and bone resorption mediated by parathyroid hormone-related protein in vivo.
    de la Mata J; Uy HL; Guise TA; Story B; Boyce BF; Mundy GR; Roodman GD
    J Clin Invest; 1995 Jun; 95(6):2846-52. PubMed ID: 7769125
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Therapy of malignancy-associated hypercalcemia: 1983.
    Stewart AF
    Am J Med; 1983 Mar; 74(3):475-80. PubMed ID: 6219580
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.